Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|June 16, 2005
mTOR--beyond transplantationDeborah A Young, Cheryl L Nickerson-Nutter
Immunologic Research|November 12, 2003
IL-21 and IL-21 receptor: a new cytokine pathway modulates innate and adaptive immunityMary Collins, Matthew J Whitters, Deborah A Young
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progressionDeborah Herber, Thomas P Brown, Spencer Liang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
IL-21 induces the apoptosis of resting and activated primary B cellsDevangi S Mehta, Andrea L Wurster, Matthew J Whitters, et al.
The Journal of Experimental Medicine|October 9, 2002
Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cellsAndrea L Wurster, Vikki L Rodgers, Abhay R Satoskar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cellsGeoffrey L Stephens, Rebecca S McHugh, Matthew J Whitters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gammaHak-Ling Ma, Matthew J Whitters, Richard F Konz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Autoreactive T cells mediate NK cell degeneration in autoimmune diseaseRuolan Liu, Luc Van Kaer, Antonio La Cava, et al.
Pageof 2